ANO1 and autosomal dominant polycystic kidney disease: Furthermore, the inhibition of TMEM16A through the FDA-approved drugs niclosamide and benzbromarone, as well as the newly discovered highly specific inhibitor Ani9, potently suppressed cyst growth in an orthologous ADPKD mouse model [9].